|
GLT8D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.243120E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.104700E-03 |
| Normal-vs-Stage2 |
4.939000E-01 |
| Normal-vs-Stage3 |
8.908600E-01 |
| Normal-vs-Stage4 |
9.334600E-01 |
| Stage1-vs-Stage2 |
2.960400E-01 |
| Stage1-vs-Stage3 |
8.694000E-02 |
| Stage1-vs-Stage4 |
1.942810E-01 |
| Stage2-vs-Stage3 |
6.870000E-01 |
| Stage2-vs-Stage4 |
6.076400E-01 |
| Stage3-vs-Stage4 |
8.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.857670E-03 |
| Normal-vs-AfricanAmerican |
3.114100E-02 |
| Normal-vs-Asian |
4.386200E-01 |
| Caucasian-vs-AfricanAmerican |
5.788800E-01 |
| Caucasian-vs-Asian |
9.417600E-01 |
| AfricanAmerican-vs-Asian |
9.117800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.057920E-02 |
| Normal-vs-Female |
2.224900E-04 |
| Male-vs-Female |
3.149800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.490840E-01 |
| Normal-vs-Extreme_Weight |
4.648200E-02 |
| Normal-vs-Obese |
1.241940E-02 |
| Normal-vs-Extreme_Obese |
8.520200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.148600E-01 |
| Normal_Weight-vs-Obese |
3.844200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.371000E-01 |
| Extreme_Weight-vs-Obese |
5.976600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.945200E-01 |
| Obese-vs-Extreme_Obese |
1.630160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.545720E-02 |
| Normal-vs-Age(41-60Yrs) |
1.575210E-03 |
| Normal-vs-Age(61-80Yrs) |
2.169500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.996000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.763400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.865800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.884800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.538600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.957000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.551400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.52909999504314E-08 |
| Normal-VS-Type2 PRCC |
1.198460E-02 |
| Normal-VS-KIRP CIMP |
3.135100E-03 |
| Normal-VS-Unclassified PRCC |
1.670190E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.62847513252018E-12 |
| Type1 PRCC-VS-KIRP CIMP |
8.456200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.202490E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.350500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.963700E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.514200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.765400E-01 |
| Normal-vs-N1 |
7.939400E-01 |
| Normal-vs-N2 |
6.865400E-01 |
| N0-vs-N1 |
7.882600E-01 |
| N0-vs-N2 |
7.782400E-01 |
| N1-vs-N2 |
8.873800E-01 |
|
|
